We are an innovative medicines company with research and development at our core. Our R&D engine powers an industry-leading pipeline focused on delivering transformative medicines to fight disease, restore possibility and help people live life on their own terms.

Researchers in Biomedical Research work across several diseases areas to uncover insights into the origins and pathogenesis of disease to drive drug discovery and early development, while the Development organization leads the advanced clinical development of those medicines, running large clinical trials and steering the way to regulatory approval and access for patients.

This work is powered by technology platforms that help us innovate across our core therapeutic areas: Cardiovascular, Renal and Metabolic, Oncology, Immunology, and Neuroscience. We focus on two established platforms – chemistry and biotherapeutics – as well as three advanced platforms – xRNA, radioligand therapy, and gene and cell therapy – we believe will continue to play an increasingly important role in delivering new medicines for patients.

Fiona H. Marshall, Ph.D

"By building on our strengths, including our long history of scientific innovation and technological leadership, we aim to discover the next generation of medicines that will make a real difference to people’s lives"

 

Fiona H. Marshall, President, Biomedical Research

Shreeram Aradhye,  President, Development and Chief Medical Officer

"Our greatest impact comes from collaborating with those who share our purpose to develop new medicines that enable physicians to change their practice and ultimately reach all people who can benefit from them."

 

Shreeram Aradhye, President, Development and Chief Medical Officer

Doctor explaining a scan to their patient

Clinical Trials

Clinical trials are at the heart of our work to bring innovative medicines to people with a particular disease or condition. These studies ensure that an investigative medicine is effective and safe, and rely entirely on patients and healthy volunteers. Learn more about clinical trials at Novartis including opportunities to get involved. 

Two scientists examine a slide

Postdoc Program

This program grants appointments to postdocs at Novartis for up to four years under dual mentorship from a Novartis mentor and an academic mentor.

two scientists collaborating

Collaborations

Our science is deeply interconnected and nimble, open and accepting of criticism, prioritized to win in a competitive landscape, and – most importantly –  impatient in its delivery to patients.

Our research benefits from an external network of more than 300 academic and 100 industry alliances focused on areas of mutual scientific interest.

Novartis looks for dedicated team members to join its research efforts around the world. We recruit the best and brightest at all levels of expertise.

Translational medicine research at Novartis

Too often, new therapies fail to bridge the treacherous gap that lies between research and entry into human clinical testing. Our team of translational medicine researchers work to bridge this gap and ensure that safe, effective and innovative treatments reach patients as quickly as possible.

Read more